JP Morgan Initiates Coverage On Phibro Animal Health with Neutral Rating, Announces Price Target of $22
Portfolio Pulse from Benzinga Newsdesk
JP Morgan has initiated coverage on Phibro Animal Health with a Neutral rating and set a price target of $22.
September 10, 2024 | 12:34 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
JP Morgan has initiated coverage on Phibro Animal Health with a Neutral rating and set a price target of $22, indicating a balanced view on the stock's potential.
The Neutral rating suggests that JP Morgan does not foresee significant upside or downside in the short term for PAHC. The price target of $22 provides a benchmark for investors, but the neutral stance indicates a balanced view on the stock's potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100